| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.568 | 0.001 | 0.568 | Acid-sensing ion channel blocker | 0.239 0.002 CID_154699557 | ||
| 0.551 | 0.014 | 0.551 | GABA C receptor rho-3 antagonist | 0.444 0.044 CID_154699674 0.339 0.092 CID_154699557 | ||
| 0.548 | 0.026 | 0.548 | Aldehyde oxidase inhibitor | 0.444 0.041 CID_154699674 0.251 0.082 CID_154699557 | ||
| 0.438 | 0.009 | 0.438 | 5 Hydroxytryptamine uptake stimulant | 0.362 0.022 CID_154699674 0.326 0.033 CID_154699557 | ||
| 0.422 | 0.017 | 0.422 | Calcium channel activator | 0.36 0.043 CID_154699674 0.324 0.069 CID_154699557 | ||
| 0.454 | 0.05 | 0.454 | 5 Hydroxytryptamine release inhibitor | 0.401 0.077 CID_154699674 0.286 0.181 CID_154699557 | ||
| 0.463 | 0.07 | 0.463 | MAP kinase 1 inhibitor | 0.243 0.242 CID_154699557 | ||
| 0.437 | 0.056 | 0.437 | Prostaglandin dehydrogenase inhibitor | |||
| 0.412 | 0.043 | 0.436 | 5 Hydroxytryptamine release stimulant | 0.436 0.039 CID_154699674 0.218 0.107 CID_154699557 | CID_154699674 | |
| 0.378 | 0.024 | 0.378 | Peroxidase inhibitor | 0.258 0.046 CID_154699674 0.174 0.067 CID_154699557 | ||
| 0.429 | 0.076 | 0.429 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.34 0.163 CID_154699674 0.3 0.213 CID_154699557 | ||
| 0.341 | 0.004 | 0.341 | Uric acid excretion stimulant | 0.122 0.037 CID_154699674 0.132 0.031 CID_154699557 | ||
| 0.323 | 0.026 | 0.323 | Ca(v)3.3 blocker | 0.237 0.121 CID_154699674 0.205 0.182 CID_154699557 | ||
| 0.354 | 0.062 | 0.354 | Cholesterol antagonist | 0.315 0.082 CID_154699674 0.299 0.092 CID_154699557 | ||
| 0.282 | 0.008 | 0.282 | DNA directed RNA polymerase inhibitor | 0.109 0.046 CID_154699674 0.155 0.023 CID_154699557 | ||
| 0.283 | 0.014 | 0.283 | Succinate dehydrogenase inhibitor | 0.248 0.023 CID_154699674 0.216 0.038 CID_154699557 | ||
| 0.387 | 0.119 | 0.393 | Caspase 9 stimulant | 0.393 0.115 CID_154699674 0.348 0.147 CID_154699557 | CID_154699674 | |
| 0.324 | 0.057 | 0.324 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.149 0.144 CID_154699674 | ||
| 0.279 | 0.018 | 0.279 | Nitric-oxide synthase stimulant | 0.23 0.049 CID_154699674 0.245 0.036 CID_154699557 | ||
| 0.291 | 0.034 | 0.291 | RNA-directed DNA polymerase inhibitor | 0.243 0.053 CID_154699674 0.219 0.075 CID_154699557 | ||
| 0.259 | 0.014 | 0.259 | Cystathionine beta-synthase inhibitor | 0.203 0.024 CID_154699674 0.175 0.031 CID_154699557 | ||
| 0.277 | 0.032 | 0.277 | Neuropeptide Y2 antagonist | 0.229 0.078 CID_154699674 0.18 0.159 CID_154699557 | ||
| 0.25 | 0.008 | 0.25 | Potassium channel (Ca-activated) activator | 0.122 0.04 CID_154699674 0.079 0.076 CID_154699557 | ||
| 0.279 | 0.039 | 0.279 | ErbB-1 antagonist | 0.226 0.066 CID_154699674 0.167 0.139 CID_154699557 | ||
| 0.265 | 0.026 | 0.265 | Interferon gamma antagonist | 0.213 0.036 CID_154699674 0.248 0.029 CID_154699557 | ||
| 0.28 | 0.044 | 0.28 | Tyrosine 3 hydroxylase inhibitor | 0.259 0.06 CID_154699674 0.194 0.146 CID_154699557 | ||
| 0.241 | 0.007 | 0.241 | Sphingosine 1-phosphate receptor 2 agonist | 0.134 0.037 CID_154699674 0.109 0.076 CID_154699557 | ||
| 0.363 | 0.132 | 0.363 | Apoptosis agonist | 0.269 0.196 CID_154699557 | ||
| 0.252 | 0.022 | 0.252 | Alpha-N-acetylglucosaminidase inhibitor | 0.172 0.044 CID_154699674 0.18 0.04 CID_154699557 | ||
| 0.263 | 0.037 | 0.263 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.191 0.08 CID_154699674 0.168 0.111 CID_154699557 | ||
| 0.303 | 0.078 | 0.303 | 12-Lipoxygenase inhibitor | 0.216 0.134 CID_154699674 | ||
| 0.249 | 0.028 | 0.249 | 3C-like protease (Human coronavirus) inhibitor | 0.219 0.042 CID_154699674 | ||
| 0.327 | 0.113 | 0.327 | 15-Lipoxygenase inhibitor | 0.233 0.179 CID_154699674 | ||
| 0.23 | 0.018 | 0.23 | Mannose-6-phosphate isomerase inhibitor | 0.154 0.061 CID_154699674 0.137 0.077 CID_154699557 | ||
| 0.226 | 0.017 | 0.226 | Ferrochelatase inhibitor | 0.114 0.058 CID_154699674 0.111 0.06 CID_154699557 | ||
| 0.231 | 0.027 | 0.231 | 5 Hydroxytryptamine 3E antagonist | 0.223 0.033 CID_154699674 0.174 0.124 CID_154699557 | ||
| 0.214 | 0.01 | 0.214 | GABA C receptor antagonist | 0.155 0.028 CID_154699674 0.145 0.033 CID_154699557 | ||
| 0.218 | 0.025 | 0.218 | ATPase inhibitor | 0.182 0.055 CID_154699674 0.218 0.025 CID_154699557 | ||
| 0.209 | 0.017 | 0.209 | CF transmembrane conductance regulator agonist | 0.181 0.036 CID_154699674 0.145 0.084 CID_154699557 | ||
| 0.216 | 0.024 | 0.216 | Aldehyde dehydrogenase inhibitor | 0.12 0.071 CID_154699674 0.103 0.092 CID_154699557 | ||
| 0.201 | 0.016 | 0.201 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.193 0.017 CID_154699674 0.118 0.04 CID_154699557 | ||
| 0.219 | 0.034 | 0.219 | Phospholipase C inhibitor | 0.18 0.061 CID_154699674 0.156 0.095 CID_154699557 | ||
| 0.191 | 0.007 | 0.191 | Potassium channel large-conductance Ca-activated activator | 0.061 0.057 CID_154699674 | ||
| 0.255 | 0.071 | 0.255 | Superoxide dismutase inhibitor | 0.222 0.096 CID_154699674 | ||
| 0.183 | 0.005 | 0.183 | Lanosterol 14 alpha demethylase inhibitor | 0.135 0.018 CID_154699674 0.124 0.027 CID_154699557 | ||
| 0.23 | 0.053 | 0.23 | Sigma receptor agonist | 0.143 0.09 CID_154699674 | ||
| 0.186 | 0.009 | 0.186 | CYP2A6 inhibitor | 0.13 0.023 CID_154699674 0.095 0.038 CID_154699557 | ||
| 0.203 | 0.027 | 0.203 | GABA C receptor rho-2 antagonist | 0.146 0.078 CID_154699674 | ||
| 0.204 | 0.028 | 0.204 | Sodium channel (voltage-gated) blocker | 0.142 0.061 CID_154699674 | ||
| 0.191 | 0.015 | 0.191 | Interleukin 8 antagonist | 0.105 0.085 CID_154699674 | ||
| 0.184 | 0.011 | 0.184 | Potassium channel activator | 0.116 0.034 CID_154699674 | ||
| 0.181 | 0.01 | 0.181 | DOPA decarboxylase inhibitor | 0.156 0.018 CID_154699674 0.125 0.04 CID_154699557 | ||
| 0.185 | 0.015 | 0.185 | Androgen antagonist | 0.131 0.028 CID_154699674 0.14 0.025 CID_154699557 | ||
| 0.176 | 0.009 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.16 0.024 CID_154699674 0.167 0.016 CID_154699557 | ||
| 0.171 | 0.005 | 0.171 | Sphingosine 1-phosphate receptor 4 agonist | 0.103 0.023 CID_154699674 0.07 0.044 CID_154699557 | ||
| 0.236 | 0.071 | 0.236 | Cyclic AMP phosphodiesterase inhibitor | 0.172 0.12 CID_154699674 0.165 0.129 CID_154699557 | ||
| 0.183 | 0.017 | 0.183 | Pregnane X receptor agonist | 0.154 0.047 CID_154699674 0.15 0.054 CID_154699557 | ||
| 0.229 | 0.064 | 0.229 | MAP kinase kinase 2 inhibitor | |||
| 0.188 | 0.023 | 0.188 | GABA C receptor agonist | 0.187 0.023 CID_154699674 0.097 0.07 CID_154699557 | ||
| 0.184 | 0.02 | 0.184 | UDP-glucose 4-epimerase inhibitor | 0.146 0.03 CID_154699674 0.161 0.025 CID_154699557 | ||
| 0.176 | 0.013 | 0.176 | NADH dehydrogenase inhibitor | 0.141 0.02 CID_154699674 0.148 0.018 CID_154699557 | ||
| 0.165 | 0.004 | 0.165 | Potassium channel intermediate-conductance Ca-activated blocker | 0.075 0.022 CID_154699674 0.065 0.033 CID_154699557 | ||
| 0.174 | 0.015 | 0.174 | Heat shock protein 70 antagonist | 0.149 0.049 CID_154699674 0.137 0.086 CID_154699557 | ||
| 0.244 | 0.086 | 0.244 | Gastrin inhibitor | 0.223 0.115 CID_154699674 | ||
| 0.244 | 0.088 | 0.244 | Transcription factor STAT3 inhibitor | |||
| 0.164 | 0.015 | 0.164 | Electrolyte absorption antagonist | 0.134 0.027 CID_154699674 0.088 0.079 CID_154699557 | ||
| 0.191 | 0.042 | 0.202 | Arachidonic acid antagonist | 0.202 0.031 CID_154699674 0.186 0.047 CID_154699557 | CID_154699674 | |
| 0.197 | 0.049 | 0.197 | Cytidine deaminase inhibitor | |||
| 0.165 | 0.019 | 0.165 | Creatine kinase inhibitor | 0.118 0.042 CID_154699674 0.104 0.055 CID_154699557 | ||
| 0.15 | 0.005 | 0.15 | Aldosterone antagonist | 0.149 0.005 CID_154699674 0.068 0.015 CID_154699557 | ||
| 0.175 | 0.032 | 0.175 | Cathepsin H inhibitor | 0.152 0.044 CID_154699674 0.122 0.072 CID_154699557 | ||
| 0.157 | 0.014 | 0.157 | MAP kinase kinase 1 inhibitor | 0.103 0.053 CID_154699674 0.088 0.073 CID_154699557 | ||
| 0.169 | 0.026 | 0.169 | 5 Hydroxytryptamine 3A agonist | 0.157 0.032 CID_154699674 | ||
| 0.162 | 0.021 | 0.162 | HIV-1 integrase (Overall Integration) inhibitor | 0.107 0.049 CID_154699674 | ||
| 0.164 | 0.023 | 0.164 | TRPA1 agonist | 0.146 0.034 CID_154699674 | ||
| 0.243 | 0.103 | 0.243 | Insulysin inhibitor | 0.215 0.136 CID_154699674 | ||
| 0.152 | 0.014 | 0.152 | HIV-1 reverse transcriptase inhibitor | |||
| 0.16 | 0.022 | 0.16 | AMP-activated protein kinase stimulant | 0.099 0.072 CID_154699674 0.127 0.044 CID_154699557 | ||
| 0.142 | 0.004 | 0.142 | Vanilloid 4 agonist | 0.127 0.005 CID_154699674 0.103 0.015 CID_154699557 | ||
| 0.151 | 0.014 | 0.151 | Cannabinoid receptor antagonist | |||
| 0.232 | 0.095 | 0.232 | 5 Hydroxytryptamine 1E antagonist | 0.231 0.095 CID_154699674 | ||
| 0.294 | 0.158 | 0.294 | Transcription factor inhibitor | |||
| 0.183 | 0.047 | 0.183 | Thiol protease inhibitor | 0.152 0.067 CID_154699674 | ||
| 0.144 | 0.008 | 0.144 | Cannabinoid CB1 receptor antagonist | 0.059 0.047 CID_154699674 | ||
| 0.181 | 0.048 | 0.181 | Hexokinase inhibitor | |||
| 0.202 | 0.069 | 0.202 | Non-steroidal antiinflammatory agent | |||
| 0.231 | 0.101 | 0.231 | Transcription factor STAT inhibitor | |||
| 0.133 | 0.003 | 0.133 | Potassium channel Kv1.1 blocker | 0.06 0.009 CID_154699674 0.049 0.014 CID_154699557 | ||
| 0.159 | 0.031 | 0.159 | MAP kinase kinase kinase inhibitor | 0.102 0.065 CID_154699674 0.086 0.08 CID_154699557 | ||
| 0.181 | 0.053 | 0.181 | Diuretic | 0.154 0.075 CID_154699674 | ||
| 0.172 | 0.044 | 0.172 | Sodium channel blocker | 0.11 0.097 CID_154699674 | ||
| 0.132 | 0.004 | 0.132 | Exportin-1 inhibitor | 0.105 0.007 CID_154699674 0.098 0.01 CID_154699557 | ||
| 0.151 | 0.025 | 0.151 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.134 | 0.008 | 0.134 | D-Ala-D-Ala ligase inhibitor | 0.109 0.02 CID_154699674 0.087 0.05 CID_154699557 | ||
| 0.13 | 0.004 | 0.13 | Urate transporter 1 inhibitor | 0.035 0.031 CID_154699674 0.046 0.021 CID_154699557 | ||
| 0.156 | 0.032 | 0.156 | Xanthine oxidase inhibitor | 0.089 0.073 CID_154699674 | ||
| 0.154 | 0.03 | 0.154 | Sphingosine 1-phosphate receptor 4 antagonist | 0.152 0.031 CID_154699674 | ||
| 0.236 | 0.114 | 0.236 | Hypoxia-inducible factor 1 alpha inhibitor | 0.224 0.125 CID_154699674 | ||
| 0.135 | 0.014 | 0.136 | Glutamate release inhibitor | 0.136 0.014 CID_154699674 0.109 0.031 CID_154699557 | CID_154699674 | |
| 0.147 | 0.026 | 0.147 | CC chemokine 6 receptor antagonist | 0.124 0.098 CID_154699674 | ||
| 0.168 | 0.049 | 0.168 | Cell wall synthesis inhibitor | 0.122 0.097 CID_154699674 | ||
| 0.122 | 0.004 | 0.122 | Dihydroorotate oxidase inhibitor | 0.103 0.005 CID_154699674 0.071 0.016 CID_154699557 | ||
| 0.13 | 0.014 | 0.13 | Nav1.7 sodium channel blocker | 0.084 0.03 CID_154699674 | ||
| 0.132 | 0.016 | 0.132 | Bromodomain-containing protein 2 inhibitor | 0.095 0.047 CID_154699674 | ||
| 0.163 | 0.047 | 0.163 | Toll-Like receptor antagonist | |||
| 0.152 | 0.038 | 0.152 | Sphingosine 1-phosphate receptor 2 antagonist | 0.142 0.052 CID_154699674 | ||
| 0.249 | 0.135 | 0.249 | Vasodilator, coronary | 0.245 0.139 CID_154699674 | ||
| 0.116 | 0.004 | 0.116 | Potassium channel (Inward rectifier) activator | 0.098 0.005 CID_154699674 0.071 0.011 CID_154699557 | ||
| 0.158 | 0.048 | 0.158 | Sphingosine 1-phosphate receptor 5 antagonist | 0.151 0.059 CID_154699674 | ||
| 0.114 | 0.004 | 0.114 | Potassium channel (ATP-sensitive) activator | 0.095 0.005 CID_154699674 0.068 0.011 CID_154699557 | ||
| 0.131 | 0.021 | 0.131 | Glutamate (mGluR7) agonist | 0.128 0.024 CID_154699674 | ||
| 0.119 | 0.01 | 0.119 | Androgen agonist | 0.09 0.019 CID_154699674 0.096 0.016 CID_154699557 | ||
| 0.15 | 0.041 | 0.15 | Protein kinase (CK2) alpha inhibitor | |||
| 0.161 | 0.053 | 0.161 | Alkaline phosphatase inhibitor | 0.108 0.104 CID_154699674 | ||
| 0.141 | 0.033 | 0.141 | Nav1.5 sodium channel blocker | 0.124 0.05 CID_154699674 | ||
| 0.135 | 0.028 | 0.135 | Acetylcholine release stimulant | 0.119 0.049 CID_154699674 | ||
| 0.241 | 0.135 | 0.241 | Vasodilator, peripheral | 0.228 0.146 CID_154699674 | ||
| 0.144 | 0.039 | 0.144 | Falcipain 3 inhibitor | 0.141 0.041 CID_154699674 | ||
| 0.119 | 0.015 | 0.119 | Purinergic P2 antagonist | |||
| 0.115 | 0.012 | 0.115 | Estrogen-related receptor beta agonist | 0.092 0.036 CID_154699674 0.089 0.042 CID_154699557 | ||
| 0.153 | 0.05 | 0.153 | MAP kinase kinase inhibitor | |||
| 0.203 | 0.101 | 0.203 | Aryl hydrocarbon receptor agonist | 0.143 0.141 CID_154699674 | ||
| 0.108 | 0.006 | 0.108 | Potassium channel (Tandem pore domain) blocker | 0.078 0.039 CID_154699674 0.075 0.047 CID_154699557 | ||
| 0.16 | 0.059 | 0.16 | Amylase inhibitor | 0.101 0.096 CID_154699674 | ||
| 0.106 | 0.007 | 0.106 | Protein kinase C theta inhibitor | |||
| 0.131 | 0.032 | 0.131 | GABA C receptor rho-1 antagonist | |||
| 0.117 | 0.018 | 0.117 | Aromatase inhibitor | 0.104 0.021 CID_154699674 0.067 0.037 CID_154699557 | ||
| 0.104 | 0.006 | 0.104 | MDM2 inhibitor | 0.091 0.011 CID_154699674 0.072 0.033 CID_154699557 | ||
| 0.113 | 0.015 | 0.113 | Glycine receptor agonist | 0.102 0.02 CID_154699674 0.088 0.03 CID_154699557 | ||
| 0.126 | 0.029 | 0.126 | Triose-phosphate isomerase inhibitor | 0.096 0.052 CID_154699674 0.087 0.064 CID_154699557 | ||
| 0.182 | 0.085 | 0.182 | Anesthetic general | 0.176 0.09 CID_154699674 | ||
| 0.121 | 0.024 | 0.121 | Inducible nitric-oxide synthase inhibitor | 0.091 0.047 CID_154699674 | ||
| 0.129 | 0.032 | 0.129 | Anabolic | 0.126 0.034 CID_154699674 0.106 0.055 CID_154699557 | ||
| 0.136 | 0.039 | 0.136 | Protein kinase (CK2) inhibitor | 0.082 0.081 CID_154699674 | ||
| 0.103 | 0.007 | 0.103 | Farnesyltransferase inhibitor | 0.044 0.035 CID_154699674 | ||
| 0.1 | 0.005 | 0.1 | Calcium channel P-type blocker | 0.08 0.015 CID_154699674 0.065 0.039 CID_154699557 | ||
| 0.149 | 0.055 | 0.149 | NADPH oxidase inhibitor | |||
| 0.138 | 0.043 | 0.138 | GABA receptor agonist | 0.105 0.071 CID_154699674 | ||
| 0.147 | 0.053 | 0.147 | Glutamate receptor antagonist | |||
| 0.102 | 0.009 | 0.102 | Progesterone antagonist | 0.066 0.013 CID_154699674 0.032 0.028 CID_154699557 | ||
| 0.101 | 0.011 | 0.101 | Fatty acid synthase inhibitor | 0.072 0.024 CID_154699674 0.069 0.026 CID_154699557 | ||
| 0.109 | 0.02 | 0.109 | Caspase 7 inhibitor | |||
| 0.103 | 0.015 | 0.103 | NMDA receptor glycine site agonist | 0.066 0.04 CID_154699674 | ||
| 0.159 | 0.071 | 0.159 | Melanin inhibitor | 0.147 0.085 CID_154699674 0.137 0.101 CID_154699557 | ||
| 0.104 | 0.017 | 0.104 | CC chemokine 5 receptor agonist | 0.091 0.035 CID_154699674 | ||
| 0.096 | 0.011 | 0.096 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.064 0.026 CID_154699674 0.048 0.046 CID_154699557 | ||
| 0.108 | 0.023 | 0.108 | Prostaglandin-E synthase inhibitor | |||
| 0.098 | 0.014 | 0.098 | Aryl hydrocarbon receptor antagonist | 0.077 0.03 CID_154699674 | ||
| 0.149 | 0.066 | 0.149 | Neuropeptide Y1 antagonist | 0.128 0.105 CID_154699674 | ||
| 0.119 | 0.036 | 0.119 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.18 | 0.097 | 0.2 | Neurotrophic factor enhancer | 0.2 0.076 CID_154699674 | CID_154699674 | |
| 0.1 | 0.017 | 0.1 | TRPA1 antagonist | |||
| 0.161 | 0.078 | 0.161 | Neurotensin receptor agonist | 0.15 0.101 CID_154699674 | ||
| 0.113 | 0.031 | 0.113 | Porphobilinogen synthase inhibitor | |||
| 0.128 | 0.047 | 0.128 | Transcription factor STAT6 inhibitor | |||
| 0.09 | 0.009 | 0.09 | Lysine-specific demethylase 1A inhibitor | 0.052 0.041 CID_154699674 | ||
| 0.122 | 0.044 | 0.122 | Beta glucuronidase inhibitor | 0.093 0.081 CID_154699674 | ||
| 0.142 | 0.063 | 0.142 | Nav1.6 sodium channel blocker | 0.126 0.088 CID_154699674 | ||
| 0.145 | 0.066 | 0.145 | Toll-Like receptor 9 antagonist | |||
| 0.108 | 0.03 | 0.108 | Cathepsin G inhibitor | 0.067 0.058 CID_154699674 | ||
| 0.237 | 0.159 | 0.237 | Calpain 2 inhibitor | |||
| 0.2 | 0.123 | 0.229 | DNA synthesis inhibitor | 0.229 0.084 CID_154699674 0.181 0.152 CID_154699557 | CID_154699674 | |
| 0.082 | 0.006 | 0.082 | CC chemokine 4 receptor antagonist | 0.051 0.027 CID_154699674 | ||
| 0.12 | 0.044 | 0.12 | Carbonic anhydrase III inhibitor | 0.093 0.07 CID_154699674 | ||
| 0.09 | 0.016 | 0.09 | Glutamate (mGluR6) antagonist | 0.087 0.018 CID_154699674 0.07 0.039 CID_154699557 | ||
| 0.096 | 0.022 | 0.096 | Acetylcholine M5 receptor agonist | 0.086 0.029 CID_154699674 | ||
| 0.114 | 0.042 | 0.114 | Nitric-oxide synthase inhibitor | |||
| 0.103 | 0.033 | 0.103 | Macrophage migration inhibitory factor inhibitor | 0.079 0.053 CID_154699674 | ||
| 0.075 | 0.004 | 0.075 | LFA antagonist | 0.033 0.012 CID_154699674 0.029 0.017 CID_154699557 | ||
| 0.134 | 0.063 | 0.134 | Cyclooxygenase 3 inhibitor | 0.133 0.064 CID_154699674 | ||
| 0.109 | 0.042 | 0.109 | Calcium antagonist | 0.094 0.052 CID_154699674 | ||
| 0.071 | 0.004 | 0.071 | Heme oxygenase inhibitor | 0.05 0.013 CID_154699674 0.046 0.02 CID_154699557 | ||
| 0.144 | 0.078 | 0.144 | MAP kinase 3 inhibitor | |||
| 0.099 | 0.033 | 0.099 | Glycine receptor antagonist | 0.09 0.042 CID_154699674 0.088 0.045 CID_154699557 | ||
| 0.132 | 0.066 | 0.132 | c-Src kinase inhibitor | 0.122 0.073 CID_154699557 | ||
| 0.076 | 0.012 | 0.076 | Glutamate (mGluR5) agonist | |||
| 0.085 | 0.021 | 0.085 | Xanthine dehydrogenase inhibitor | |||
| 0.079 | 0.015 | 0.079 | Heme oxygenase stimulant | 0.06 0.046 CID_154699674 0.059 0.048 CID_154699557 | ||
| 0.101 | 0.038 | 0.101 | I kappa B kinase inhibitor | |||
| 0.086 | 0.022 | 0.086 | Alcohol oxidase inhibitor | 0.049 0.046 CID_154699674 | ||
| 0.114 | 0.051 | 0.114 | Urease inhibitor | |||
| 0.089 | 0.027 | 0.089 | GABA B receptor agonist | 0.081 0.041 CID_154699674 | ||
| 0.066 | 0.004 | 0.066 | Vanilloid 3 antagonist | 0.059 0.005 CID_154699674 0.046 0.013 CID_154699557 | ||
| 0.085 | 0.024 | 0.085 | Potassium channel (ATP-sensitive) blocker | |||
| 0.071 | 0.009 | 0.071 | Purinergic P2X4 antagonist | 0.049 0.026 CID_154699674 | ||
| 0.112 | 0.051 | 0.112 | Adenylate kinase inhibitor | 0.096 0.074 CID_154699674 | ||
| 0.079 | 0.018 | 0.079 | Toll-Like receptor 8 antagonist | |||
| 0.068 | 0.006 | 0.068 | Glutamate (mGluR3) antagonist | 0.051 0.012 CID_154699674 | ||
| 0.095 | 0.034 | 0.095 | Glutamate dehydrogenase inhibitor | 0.076 0.048 CID_154699674 0.07 0.057 CID_154699557 | ||
| 0.094 | 0.034 | 0.094 | Histidine decarboxylase inhibitor | |||
| 0.08 | 0.02 | 0.08 | Cannabinoid CB2 receptor antagonist | |||
| 0.064 | 0.005 | 0.064 | CXC chemokine 2 receptor antagonist | 0.026 0.019 CID_154699674 | ||
| 0.072 | 0.012 | 0.072 | Pregnane X receptor antagonist | 0.066 0.02 CID_154699674 0.055 0.046 CID_154699557 | ||
| 0.065 | 0.005 | 0.065 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.019 CID_154699674 0.042 0.027 CID_154699557 | ||
| 0.078 | 0.019 | 0.078 | Botulinum neurotoxin type A inhibitor | |||
| 0.089 | 0.031 | 0.089 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.079 | 0.021 | 0.079 | Heat shock protein 90 beta antagonist | 0.062 0.037 CID_154699674 0.062 0.036 CID_154699557 | ||
| 0.076 | 0.018 | 0.076 | AMPA receptor antagonist | |||
| 0.143 | 0.086 | 0.143 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.066 | 0.008 | 0.066 | Purinergic P2X7 antagonist | |||
| 0.067 | 0.009 | 0.067 | GABA B receptor antagonist | 0.053 0.017 CID_154699674 | ||
| 0.086 | 0.029 | 0.086 | Secretase beta inhibitor | 0.074 0.044 CID_154699674 | ||
| 0.089 | 0.032 | 0.089 | Benzodiazepine agonist | |||
| 0.061 | 0.004 | 0.061 | MAP3K8 inhibitor | 0.034 0.012 CID_154699674 0.032 0.014 CID_154699557 | ||
| 0.083 | 0.027 | 0.083 | NMDA receptor agonist | 0.06 0.047 CID_154699674 | ||
| 0.123 | 0.067 | 0.123 | DNA repair enzyme inhibitor | |||
| 0.064 | 0.009 | 0.064 | Sirtuin 2 inhibitor | 0.05 0.013 CID_154699674 | ||
| 0.11 | 0.055 | 0.11 | MAO B inhibitor | 0.08 0.076 CID_154699674 | ||
| 0.084 | 0.029 | 0.084 | Phospholipase D inhibitor | |||
| 0.078 | 0.024 | 0.078 | I kappa B kinase 2 inhibitor | |||
| 0.071 | 0.016 | 0.071 | Glutamate (mGluR group I) agonist | 0.044 0.037 CID_154699674 | ||
| 0.086 | 0.032 | 0.086 | Toll-Like receptor 7 antagonist | |||
| 0.162 | 0.107 | 0.162 | I kappa B kinase epsilon inhibitor | 0.156 0.113 CID_154699674 | ||
| 0.071 | 0.017 | 0.071 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.095 | 0.041 | 0.095 | Glutamate receptor agonist | |||
| 0.066 | 0.013 | 0.066 | Dihydroorotase inhibitor | |||
| 0.075 | 0.022 | 0.075 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.052 CID_154699674 | ||
| 0.067 | 0.016 | 0.088 | Mineralocorticoid receptor antagonist | 0.088 0.009 CID_154699674 | CID_154699674 | |
| 0.069 | 0.017 | 0.069 | Glutamate (mGluR5) antagonist | |||
| 0.055 | 0.005 | 0.055 | Geranylgeranyltransferase I inhibitor | |||
| 0.069 | 0.019 | 0.069 | Nicotinic alpha3beta2 receptor antagonist | 0.059 0.027 CID_154699674 | ||
| 0.057 | 0.007 | 0.057 | Cathepsin F inhibitor | 0.046 0.019 CID_154699674 0.043 0.025 CID_154699557 | ||
| 0.073 | 0.023 | 0.073 | Kallikrein 7 inhibitor | 0.062 0.049 CID_154699674 | ||
| 0.137 | 0.088 | 0.141 | Adenylate cyclase stimulant | 0.141 0.078 CID_154699674 | CID_154699674 | |
| 0.167 | 0.118 | 0.167 | Histone acetyltransferase inhibitor | |||
| 0.164 | 0.115 | 0.164 | Insulin sensitizer | |||
| 0.084 | 0.036 | 0.084 | Calcium channel L-type blocker | |||
| 0.15 | 0.102 | 0.15 | Amyloid beta precursor protein antagonist | |||
| 0.068 | 0.02 | 0.068 | Aconitate hydratase inhibitor | 0.06 0.026 CID_154699674 | ||
| 0.077 | 0.03 | 0.077 | Carbamoyl phosphate synthetase inhibitor | 0.064 0.039 CID_154699674 0.055 0.048 CID_154699557 | ||
| 0.058 | 0.011 | 0.058 | Nerve growth factor antagonist | |||
| 0.096 | 0.049 | 0.096 | Histamine N-methyltransferase inhibitor | |||
| 0.089 | 0.043 | 0.089 | Catalase inhibitor | |||
| 0.053 | 0.006 | 0.053 | Kynurenine 3 monooxygenase inhibitor | 0.037 0.011 CID_154699674 | ||
| 0.053 | 0.007 | 0.053 | ATP citrate lysase inhibitor | 0.038 0.014 CID_154699674 0.052 0.007 CID_154699557 | ||
| 0.066 | 0.02 | 0.066 | Potassium channel (Inward rectifier) blocker | |||
| 0.081 | 0.035 | 0.081 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.065 | 0.02 | 0.065 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.1 | 0.055 | 0.1 | Prolactin inhibitor | 0.093 0.063 CID_154699674 | ||
| 0.049 | 0.005 | 0.049 | Nicotinic alpha3beta4 receptor agonist | 0.041 0.01 CID_154699674 0.03 0.021 CID_154699557 | ||
| 0.056 | 0.012 | 0.056 | Phosphoglycerate kinase inhibitor | 0.032 0.028 CID_154699557 | ||
| 0.119 | 0.075 | 0.119 | MAO inhibitor | |||
| 0.084 | 0.041 | 0.084 | GABA aminotransferase inhibitor | 0.077 0.05 CID_154699674 | ||
| 0.063 | 0.021 | 0.063 | Purinergic P2X antagonist | |||
| 0.084 | 0.042 | 0.084 | Estrogen receptor alpha antagonist | 0.074 0.058 CID_154699674 0.075 0.057 CID_154699557 | ||
| 0.055 | 0.013 | 0.055 | Glutamate (mGluR group II) antagonist | |||
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR4) antagonist | 0.041 0.034 CID_154699674 | ||
| 0.055 | 0.014 | 0.057 | Dopamine D5 agonist | 0.057 0.013 CID_154699674 | CID_154699674 | |
| 0.159 | 0.118 | 0.159 | Anticonvulsant | |||
| 0.113 | 0.072 | 0.119 | Cholesterol synthesis inhibitor | 0.119 0.066 CID_154699674 | CID_154699674 | |
| 0.049 | 0.009 | 0.049 | Free fatty acid receptor 1 antagonist | 0.039 0.017 CID_154699674 | ||
| 0.065 | 0.025 | 0.065 | 5 Hydroxytryptamine 7 agonist | 0.053 0.046 CID_154699674 | ||
| 0.048 | 0.008 | 0.048 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 CID_154699674 | ||
| 0.05 | 0.011 | 0.05 | Integrin alpha2 antagonist | 0.034 0.032 CID_154699674 | ||
| 0.046 | 0.007 | 0.046 | Sodium/glucose cotransporter 2 inhibitor | 0.029 0.015 CID_154699674 0.041 0.008 CID_154699557 | ||
| 0.152 | 0.114 | 0.152 | Pyruvate kinase inhibitor | |||
| 0.102 | 0.065 | 0.102 | Carbonic anhydrase XV inhibitor | 0.094 0.076 CID_154699674 | ||
| 0.051 | 0.014 | 0.051 | AMPA 4 receptor antagonist | |||
| 0.069 | 0.033 | 0.069 | Biliverdin reductase inhibitor | |||
| 0.096 | 0.059 | 0.096 | Bile acid receptor antagonist | |||
| 0.061 | 0.025 | 0.061 | Dipeptidyl peptidase inhibitor | 0.051 0.04 CID_154699674 | ||
| 0.057 | 0.021 | 0.057 | Glucose-6-phosphate isomerase inhibitor | 0.054 0.024 CID_154699674 0.048 0.033 CID_154699557 | ||
| 0.053 | 0.018 | 0.053 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.04 | 0.006 | 0.04 | Geranylgeranyltransferase inhibitor | 0.022 0.015 CID_154699674 | ||
| 0.076 | 0.041 | 0.076 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.087 | 0.052 | 0.087 | Glutathione S-transferase inhibitor | |||
| 0.039 | 0.005 | 0.039 | Hedgehog signaling activator | 0.036 0.006 CID_154699674 0.029 0.014 CID_154699557 | ||
| 0.068 | 0.034 | 0.068 | Transcription factor RelA inhibitor | 0.06 0.057 CID_154699674 | ||
| 0.07 | 0.035 | 0.07 | Cannabinoid CB1 receptor agonist | |||
| 0.052 | 0.018 | 0.052 | Dipeptidyl peptidase IV inhibitor | 0.044 0.032 CID_154699674 | ||
| 0.052 | 0.018 | 0.052 | Parathyroid hormone antagonist | |||
| 0.046 | 0.012 | 0.046 | CF transmembrane conductance regulator antagonist | 0.039 0.032 CID_154699674 | ||
| 0.119 | 0.085 | 0.119 | Nav1.2 sodium channel blocker | |||
| 0.055 | 0.022 | 0.055 | CC chemokine 3 receptor antagonist | |||
| 0.13 | 0.096 | 0.13 | Hemostatic | 0.122 0.11 CID_154699674 | ||
| 0.047 | 0.014 | 0.047 | Estrogen-related receptor alpha antagonist | |||
| 0.055 | 0.022 | 0.055 | Purinergic P2Y antagonist | |||
| 0.081 | 0.048 | 0.081 | Glutamate (mGluR) antagonist | |||
| 0.096 | 0.064 | 0.096 | Sphingomyelinase inhibitor | 0.085 0.079 CID_154699674 0.087 0.076 CID_154699557 | ||
| 0.058 | 0.026 | 0.058 | Prolyl endopeptidase inhibitor | |||
| 0.066 | 0.035 | 0.066 | Purinergic P2X1 antagonist | 0.055 0.052 CID_154699674 | ||
| 0.053 | 0.022 | 0.053 | Sphingosine 1-phosphate receptor agonist | |||
| 0.063 | 0.032 | 0.063 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.08 | 0.05 | 0.08 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.087 | 0.057 | 0.087 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.056 | 0.027 | 0.056 | Glycine transporter inhibitor | |||
| 0.04 | 0.012 | 0.04 | Glutamate (mGluR2) antagonist | |||
| 0.046 | 0.018 | 0.046 | Vascular adhesion protein 1 inhibitor | |||
| 0.04 | 0.012 | 0.04 | Uridine phosphorylase inhibitor | |||
| 0.037 | 0.009 | 0.037 | Nicotinic alpha4beta2 receptor agonist | 0.036 0.01 CID_154699674 | ||
| 0.046 | 0.018 | 0.046 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.045 | 0.018 | 0.045 | 5 Hydroxytryptamine 2B agonist | 0.04 0.025 CID_154699674 | ||
| 0.073 | 0.046 | 0.073 | Phosphofructokinase-1 inhibitor | 0.064 0.053 CID_154699674 0.065 0.052 CID_154699557 | ||
| 0.137 | 0.11 | 0.151 | Antipruritic | 0.151 0.093 CID_154699674 | CID_154699674 | |
| 0.04 | 0.013 | 0.04 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.038 | 0.012 | 0.038 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.022 CID_154699674 | ||
| 0.107 | 0.081 | 0.127 | Beta amyloid protein antagonist | 0.127 0.06 CID_154699557 | CID_154699557 | |
| 0.072 | 0.046 | 0.072 | Glutamate (mGluR group I) antagonist | |||
| 0.083 | 0.057 | 0.151 | T cell inhibitor | 0.151 0.01 CID_154699557 | CID_154699557 | |
| 0.057 | 0.031 | 0.057 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.039 | 0.014 | 0.039 | Cholesterol ester transfer protein antagonist | 0.03 0.024 CID_154699674 | ||
| 0.039 | 0.013 | 0.039 | Liver X receptor beta antagonist | |||
| 0.044 | 0.019 | 0.044 | Farnesoid X receptor agonist | 0.036 0.029 CID_154699674 | ||
| 0.047 | 0.021 | 0.047 | Thymidine kinase inhibitor | |||
| 0.082 | 0.057 | 0.082 | ALK inhibitor | |||
| 0.094 | 0.069 | 0.094 | Aminopeptidase B inhibitor | |||
| 0.083 | 0.058 | 0.083 | GABA A receptor agonist | |||
| 0.066 | 0.041 | 0.066 | 5 Hydroxytryptamine 2A agonist | 0.065 0.042 CID_154699674 | ||
| 0.034 | 0.009 | 0.034 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 CID_154699674 0.03 0.011 CID_154699557 | ||
| 0.213 | 0.188 | 0.213 | Histamine release inhibitor | 0.211 0.19 CID_154699674 | ||
| 0.039 | 0.015 | 0.039 | Dipeptidyl peptidase II inhibitor | |||
| 0.04 | 0.016 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.1 | 0.076 | 0.1 | EphA2 antagonist | |||
| 0.034 | 0.01 | 0.034 | NMDA receptor glycine site antagonist | |||
| 0.029 | 0.005 | 0.029 | Cyclin T1 inhibitor | 0.022 0.009 CID_154699674 | ||
| 0.062 | 0.039 | 0.062 | Alpha 2 adrenoreceptor agonist | 0.057 0.046 CID_154699674 | ||
| 0.054 | 0.031 | 0.054 | CXC chemokine 1 receptor antagonist | |||
| 0.037 | 0.015 | 0.037 | Vanilloid 4 antagonist | |||
| 0.125 | 0.103 | 0.125 | Src kinase inhibitor | |||
| 0.057 | 0.035 | 0.057 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.027 | 0.005 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.012 CID_154699674 | ||
| 0.072 | 0.05 | 0.072 | Aminopeptidase I inhibitor | |||
| 0.06 | 0.038 | 0.06 | Dopamine uptake inhibitor | |||
| 0.088 | 0.066 | 0.088 | Polo-like kinase-1 inhibitor | |||
| 0.054 | 0.033 | 0.054 | 5 Hydroxytryptamine 2 agonist | 0.054 0.033 CID_154699674 | ||
| 0.041 | 0.02 | 0.041 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.045 | 0.024 | 0.045 | Liver X receptor alpha agonist | |||
| 0.029 | 0.008 | 0.029 | Imidazoline I1 receptor antagonist | 0.022 0.012 CID_154699674 | ||
| 0.052 | 0.031 | 0.052 | Squalene epoxidase inhibitor | |||
| 0.046 | 0.025 | 0.046 | Histamine H1 receptor agonist | |||
| 0.073 | 0.052 | 0.073 | Glutamate decarboxylase inhibitor | |||
| 0.045 | 0.025 | 0.045 | Kainate receptor antagonist | |||
| 0.036 | 0.017 | 0.036 | Protein kinase (CK2) beta inhibitor | 0.035 0.018 CID_154699674 | ||
| 0.027 | 0.008 | 0.027 | Progesterone agonist | |||
| 0.024 | 0.005 | 0.024 | CC chemokine 9 receptor antagonist | 0.016 0.014 CID_154699674 | ||
| 0.134 | 0.115 | 0.134 | LIM domain kinase 1 inhibitor | |||
| 0.102 | 0.084 | 0.102 | Interleukin 2 antagonist | |||
| 0.042 | 0.024 | 0.042 | Alpha 1d adrenoreceptor agonist | |||
| 0.087 | 0.069 | 0.087 | Alcohol dehydrogenase inhibitor | |||
| 0.036 | 0.019 | 0.036 | Liver X receptor beta agonist | |||
| 0.035 | 0.018 | 0.035 | Potassium channel small-conductance Ca-activated activator | |||
| 0.042 | 0.026 | 0.042 | Kainate receptor agonist | 0.04 0.031 CID_154699674 | ||
| 0.03 | 0.013 | 0.03 | Integrin alpha2beta1 antagonist | |||
| 0.055 | 0.039 | 0.055 | MAP kinase kinase 9 inhibitor | |||
| 0.066 | 0.05 | 0.071 | Glutamate (mGluR7) antagonist | 0.071 0.04 CID_154699674 | CID_154699674 | |
| 0.074 | 0.058 | 0.074 | Keratolytic | |||
| 0.029 | 0.013 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.02 CID_154699674 | ||
| 0.103 | 0.087 | 0.103 | Caspase 3 inhibitor | |||
| 0.057 | 0.042 | 0.057 | Cathepsin L inhibitor | 0.054 0.045 CID_154699674 | ||
| 0.039 | 0.023 | 0.039 | Delayed rectifier potassium channel blocker | 0.037 0.026 CID_154699674 | ||
| 0.068 | 0.053 | 0.068 | Amidase inhibitor | |||
| 0.034 | 0.019 | 0.034 | Estrogen-related receptor beta antagonist | |||
| 0.038 | 0.023 | 0.038 | Kainate receptor 2 antagonist | |||
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.039 | 0.024 | 0.041 | Glutamate (mGluR8) agonist | 0.041 0.022 CID_154699674 | CID_154699674 | |
| 0.067 | 0.052 | 0.067 | I kappa B kinase 1 inhibitor | |||
| 0.06 | 0.045 | 0.06 | NMDA 2C receptor antagonist | |||
| 0.059 | 0.045 | 0.059 | Cyclin D1 inhibitor | |||
| 0.048 | 0.034 | 0.048 | Dopamine beta hydroxylase inhibitor | |||
| 0.046 | 0.032 | 0.049 | Adenylate cyclase 1 inhibitor | 0.049 0.028 CID_154699674 | CID_154699674 | |
| 0.043 | 0.029 | 0.043 | Guanylate cyclase inhibitor | 0.042 0.031 CID_154699674 | ||
| 0.021 | 0.008 | 0.021 | Complement factor D inhibitor | 0.018 0.013 CID_154699674 | ||
| 0.081 | 0.069 | 0.081 | Falcipain 2 inhibitor | |||
| 0.039 | 0.027 | 0.039 | Cathepsin L1 inhibitor | 0.036 0.031 CID_154699674 | ||
| 0.042 | 0.031 | 0.042 | Glutamate (mGluR group III) agonist | |||
| 0.079 | 0.067 | 0.079 | Transforming growth factor beta 3 antagonist | |||
| 0.035 | 0.023 | 0.035 | Fumarate hydratase inhibitor | |||
| 0.036 | 0.024 | 0.036 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.053 | 0.042 | 0.053 | Sphingosine kinase 2 inhibitor | |||
| 0.122 | 0.111 | 0.122 | Heat shock protein 90 antagonist | |||
| 0.044 | 0.033 | 0.044 | Fructose-1,6-bisphosphatase inhibitor | 0.041 0.037 CID_154699674 | ||
| 0.019 | 0.008 | 0.019 | Nicotinic alpha4 receptor agonist | 0.017 0.01 CID_154699674 | ||
| 0.017 | 0.006 | 0.017 | CC chemokine 10 receptor antagonist | |||
| 0.027 | 0.017 | 0.027 | Thyroid hormone agonist | |||
| 0.082 | 0.072 | 0.082 | Falcipain inhibitor | |||
| 0.079 | 0.069 | 0.079 | Ornithine decarboxylase inhibitor | |||
| 0.029 | 0.019 | 0.029 | Purinergic P2Y15 antagonist | 0.027 0.023 CID_154699674 | ||
| 0.014 | 0.004 | 0.014 | Progesterone receptor A antagonist | 0.013 0.005 CID_154699674 0.009 0.008 CID_154699557 | ||
| 0.034 | 0.024 | 0.034 | Factor XI inhibitor | |||
| 0.079 | 0.069 | 0.079 | Myeloperoxidase inhibitor | |||
| 0.05 | 0.041 | 0.05 | Thromboxane antagonist | |||
| 0.029 | 0.02 | 0.029 | 5 Hydroxytryptamine 6 agonist | |||
| 0.028 | 0.02 | 0.028 | Estrogen-related receptor gamma antagonist | |||
| 0.026 | 0.017 | 0.026 | Complement factor 1s inhibitor | |||
| 0.046 | 0.038 | 0.046 | Histamine H4 receptor antagonist | |||
| 0.042 | 0.033 | 0.042 | NMDA receptor subunit 3B antagonist | |||
| 0.023 | 0.014 | 0.035 | Glutamate (mGluR1a) agonist | 0.035 0.007 CID_154699674 | CID_154699674 | |
| 0.017 | 0.01 | 0.017 | Dipeptidyl peptidase IX inhibitor | |||
| 0.024 | 0.016 | 0.024 | CC chemokine 1 receptor antagonist | |||
| 0.019 | 0.011 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.045 | 0.038 | 0.045 | Benzodiazepine antagonist | |||
| 0.046 | 0.039 | 0.046 | Thromboxane A2 antagonist | |||
| 0.047 | 0.041 | 0.047 | Factor IXa inhibitor | |||
| 0.031 | 0.025 | 0.037 | Glutamate (mGluR3) agonist | 0.037 0.013 CID_154699674 | CID_154699674 | |
| 0.019 | 0.013 | 0.019 | Alpha 2c adrenoreceptor agonist | |||
| 0.014 | 0.008 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.032 | 0.027 | 0.032 | Glutamate (mGluR4) agonist | |||
| 0.013 | 0.008 | 0.013 | Integrin beta2 antagonist | |||
| 0.008 | 0.003 | 0.008 | CC chemokine 6 receptor agonist | |||
| 0.028 | 0.023 | 0.028 | Glucagon receptor antagonist | |||
| 0.016 | 0.01 | 0.016 | Thromboxane A2 agonist | 0.015 0.011 CID_154699674 | ||
| 0.041 | 0.036 | 0.041 | Phosphorylase inhibitor | |||
| 0.104 | 0.099 | 0.104 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.037 | 0.032 | 0.037 | GABA uptake inhibitor | |||
| 0.054 | 0.049 | 0.054 | Leukotriene C antagonist | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.018 | 0.014 | 0.018 | Cathepsin S inhibitor | |||
| 0.032 | 0.028 | 0.032 | RNA-directed RNA polymerase inhibitor | |||
| 0.082 | 0.078 | 0.082 | MAO A inhibitor | |||
| 0.037 | 0.033 | 0.037 | Factor XIa inhibitor | |||
| 0.028 | 0.025 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.031 | 0.029 | 0.034 | Glucose-dependent insulinotropic receptor agonist | 0.034 0.025 CID_154699674 | CID_154699674 | |
| 0.016 | 0.014 | 0.016 | Alpha 2a adrenoreceptor agonist | |||
| 0.04 | 0.038 | 0.04 | Alpha 1L adrenoreceptor agonist | |||
| 0.049 | 0.048 | 0.049 | Heparanase inhibitor | |||
| 0.033 | 0.032 | 0.035 | G protein-coupled receptor agonist | 0.035 0.029 CID_154699674 | CID_154699674 | |
| 0.039 | 0.038 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.02 | 0.02 | 0.022 | Prostaglandin E2 agonist | 0.022 0.018 CID_154699674 | CID_154699674 | |
| 0.021 | 0.022 | 0.022 | Prostaglandin H2 antagonist | 0.022 0.021 CID_154699674 | CID_154699674 | |
| 0.027 | 0.027 | 0.03 | Prostaglandin agonist | 0.03 0.022 CID_154699674 | CID_154699674 | |
| 0.095 | 0.099 | 0.118 | Photosensitizer | 0.118 0.059 CID_154699674 | CID_154699674 | |
| 0.044 | 0.051 | 0.294 | Janus tyrosine kinase 1 inhibitor | 0.294 0.004 CID_154699674 | CID_154699674 | |
| 0.021 | 0.031 | 0.024 | Vanilloid 2 agonist | 0.024 0.022 CID_154699674 | CID_154699674 | |
| 0.046 | 0.061 | 0.116 | Tyk2 inhibitor | 0.116 0.022 CID_154699674 | CID_154699674 | |
| 0.091 | 0.109 | 0.137 | Microtubule formation inhibitor | 0.137 0.045 CID_154699674 | CID_154699674 | |
| 0.052 | 0.081 | 0.075 | Na+ K+ transporting ATPase inhibitor | 0.075 0.055 CID_154699674 | CID_154699674 | |
| 0.062 | 0.145 | 0.1 | Thioredoxin reductase inhibitor | 0.1 0.029 CID_154699557 | CID_154699557 | |
| 0.031 | 0.139 | 0.269 | Janus tyrosine kinase 2 inhibitor | 0.269 0.006 CID_154699674 | CID_154699674 | |
| 0.051 | 0.356 | 0.137 | Nitric oxide antagonist | 0.137 0.109 CID_154699557 | CID_154699557 | |
| 0.019 | 0.464 | 0.118 | ATPase (Vacuolar H+) inhibitor | 0.118 0.021 CID_154699557 | CID_154699557 | |
| 0.079 | 0.779 | 0.247 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.247 0.069 CID_154699674 | CID_154699674 | |
| 0.017 | 0.793 | 0.281 | Immunosuppressant | 0.281 0.127 CID_154699557 | CID_154699557 | |
| 0.006 | 0.807 | 0.053 | Protein 50S ribosomal subunit inhibitor | 0.053 0.037 CID_154699557 | CID_154699557 | |
| 0.003 | 0.906 | 0.152 | Microtubule stabilization | 0.152 0.002 CID_154699674 | CID_154699674 | |
| 0.005 | 0.927 | 0.795 | Antimitotic | 0.795 0.004 CID_154699674 | CID_154699674 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |